CD276 and urinary bladder carcinoma: This complex regulation may account for the observed differences between CD276 gene expression and B7‐H3 protein levels in relation to pCR in bladder cancer patients, emphasizing the importance of directly assessing protein expression when investigating potential biomarkers.